Invention Grant
- Patent Title: Substituted imidazoquinolines as agonists of TLR7
-
Application No.: US16644079Application Date: 2018-08-31
-
Publication No.: US11279684B2Publication Date: 2022-03-22
- Inventor: Christophe Henry
- Applicant: BIONTECH SE
- Applicant Address: DE Mainz
- Assignee: BIONTECH SE
- Current Assignee: BIONTECH SE
- Current Assignee Address: DE Mainz
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- Priority: WOPCT/EP2017/072353 20170906
- International Application: PCT/EP2018/073485 WO 20180831
- International Announcement: WO2019/048353 WO 20190314
- Main IPC: A61P35/00
- IPC: A61P35/00 ; C07D471/04 ; C07D401/04
Abstract:
The invention relates to imidazoquinoline derivatives and to pharmaceutical compositions containing the imidazoquinoline derivatives. The imidazoquinoline derivatives of the invention are useful as toll-like receptor agonists, in particular agonists of TLR7, and promote induction of certain cytokines.
Public/Granted literature
- US20210002249A1 SUBSTITUTED IMIDAZOQUINOLINES AS AGONISTS OF TLR7 Public/Granted day:2021-01-07
Information query
IPC分类:
| A | 人类生活必需 |
| A61 | 医学或兽医学；卫生学 |
| A61P | 化合物或药物制剂的特定治疗活性 |
| A61P35/00 | 抗肿瘤药 |
